DENTSPLY SIRONA Inc.
NASDAQ:XRAY · NASDAQ Global Select
+$0.19 today
Vol 4.67M · Avg 4.70M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-44.6%
avg -12.3%
ROIC
5.7%
avg -3.1%
ROA
-11.0%
avg -4.7%
Analysis
ROIC is currently the strongest return metric at 5.7% versus its period average of -3.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Daniel T. Scavilla | President, Chief Executive Officer, Interim Principal Financial Officer & Director | $2.05M | — | 61 | $157,754.00 | 0.08% |
Aldo Denti | Executive Vice President & Chief Commercial Officer | $1.51M | — | 58 | $829.40 | <0.01% |
Robert Anthony Johnson | Senior Vice President, Chief Supply Chain Officer & Head of Sustainability | $926,015.00 | — | 57 | $202,700.00 | 0.10% |
Andrea L. Frohning | Senior Vice President & Chief Human Resources Officer | $775,720.00 | — | 56 | $121,600.00 | 0.06% |
Wade Moody | Senior Manager of Investor Relations | — | — | — | — | — |
Lindi Barton-Brobst | Interim General Counsel & Assistant Secretary | — | — | — | — | — |
David Ferguson | Senior Vice President of Global Business Unit Leader | — | — | — | — | — |
Kevin Boyle | Senior Vice President & Chief Technology Officer | — | — | — | $6,346.98 | <0.01% |
Kevin Czerney | Vice President & Chief Accounting Officer | — | — | 42 | $6,346.98 | <0.01% |
Michael C. Pomeroy | Interim Chief Financial Officer | — | — | 68 | $55,943.00 | 0.03% |
Emily Miner | Senior Vice President of Global Quality and Regulatory & Chief Quality Officer | — | — | — | — | — |
Dane Baumgardner | Attorney-In-Fact | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
11
$1.64M
Sells
1
$915,708.00
Net Sentiment
+$723,890.12
Net buying
Most Active
LUCIER GREGORY T
4 transactions
1–10 of 12
Analysis
Insiders reported 11 buys worth $1.64M and 1 sells worth $915,708.00 over the last 12 months. That adds up to net buying of $723,890.12. LUCIER GREGORY T was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -6.9% | -0.2% (14yr)4 analysts |
| Revenue | N/A | N/A | -3.0% | +2.5% (14yr)5 analysts |
| Net Income | N/A | N/A | -7.2% | +2.2% (14yr)5 analysts |
| EBIT | N/A | N/A | -0.6% | N/A5 analysts |
Analysis
Recent growth has been strongest in EBIT at -0.6% over three years. Forward estimates point to Revenue at +2.5% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.66B
ICU Medical, Inc.
NASDAQ:ICUI
$3.49B
Beam Therapeutics Inc.
NASDAQ:BEAM
$3.40B
Haemonetics Corporation
NYSE:HAE
$3.34B
Warby Parker Inc.
NYSE:WRBY
$3.09B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.14B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$2.00B
Bausch Health Companies Inc.
NYSE:BHC
$1.74B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.42B
QuidelOrtho Corporation
NASDAQ:QDEL
$904.21M
Who manages XRAY?
DENTSPLY SIRONA Inc. (XRAY) lists 12 active executives. The top listed executive is Daniel T. Scavilla, President, Chief Executive Officer, Interim Principal Financial Officer & Director.
Are XRAY insiders buying or selling?
Recent insider activity shows net buying of $82.83M.
Explore More
Continue the stock analysis
Jump to another research area for this company.